The Effects of Ergonomics Awareness Education and Exercise

• Sponsor: Istanbul Kültür University (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05475353
• Collaborator: (none)
• Enrollment: 12
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 7.4
• Patients Per Site Per Month: 1.6

Study Details

Study Description

Brief Summary

This study aims to determine the effects of asynchronous and synchronous exercises, which are added to ergonomics awareness education, on musculoskeletal disorders, physical activity and quality of life.

Condition or Disease	Intervention/Treatment	Phase
Ergonomics; Telerehabilitation; Musculoskeletal System Disorder; Quality of Life	Behavioral: Asyncronized Exercise; Procedure: Syncronized Exercise	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 12 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: The Effects of Ergonomics Awareness Education and Exercise on Physical Activity, Quality of Life, and Musculoskeletal Discomfort in Remote Workers
• Actual Study Start Date: Jan 20, 2022
• Anticipated Primary Completion Date: Jul 1, 2022
• Anticipated Study Completion Date: Sep 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Asyncronized Exercise Group - Ergonomics awareness education and exercise suggestions	Behavioral: Asyncronized Exercise; This group will be informed about ergonomics and protective exercises for the musculoskeletal system with an online seminar.
Experimental: Syncronized Exercise Group - Ergonomics awareness education and than 6 weeks online supervised exercise training	Procedure: Syncronized Exercise; This group will be informed about ergonomics and protective exercises for the musculoskeletal system with an online seminar. Then, participants will complete the 6 weeks of exercise training at an online video conference program two times a week under the physiotherapist's supervise.

Outcome Measures

Primary Outcome Measures

1. Physical activty status [Baseline]

   International Physical. Activity Questionnaire-short form

2. Physical activty status [6 weeks]

   International Physical. Activity Questionnaire-short form

3. Quality of life status [Baseline]

   Short Form 36

4. Quality of life status [6 weeks]

   Short Form 36

5. Musculoskeletal Discomfort level [Baseline]

   Cornell Musculoskeletal Discomfort Questionnaires: Higher scores indicate higher musculoskeletal discomfort.

6. Musculoskeletal Discomfort level [6 weeks]

   Cornell Musculoskeletal Discomfort Questionnaires: Higher scores indicate higher musculoskeletal discomfort.

7. Ergonomic risk level [Baseline]

   Rapid Upper Limb Assesment: Higher scores indicate higher risk.

8. Ergonomic risk level [6 weeks]

   Rapid Upper Limb Assesment: Higher scores indicate higher risk.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 45 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Aged between 18-45

• Working at home at least 5 hours a day

• Not having one or more diagnosed musculoskeletal disorders

Exclusion Criteria:

• Limited access to technology or not being able to actively use the technology

• Had musculoskeletal trauma or surgery

• Pregnancy

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	İstanbul Kültür Üniversitesi	Istanbul		Turkey

Sponsors and Collaborators

• Istanbul Kültür University

Investigators

• Study Director: Halenur Evrendilek, Res. Asst., İstanbul Kültür University
• Study Director: Burcu Semin Akel, Prof. Dr., İstanbul Kültür University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Halenur Evrendilek, Research Assistant, Istanbul Kültür University
• ClinicalTrials.gov Identifier: NCT05475353
• Other Study ID Numbers: 2/2021.K-20
• First Posted: Jul 26, 2022
• Last Update Posted: Jul 26, 2022
• Last Verified: Jul 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Musculoskeletal Diseases

Study Results

No Results Posted as of Jul 26, 2022